Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1211-1216

  Simpson, David J ^a   Hibberts, Nigel A ^a   McNicol, Anne Marie ^a,b   Clayton, Richard N ^a   Farrell, William E ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN;

ALLELE; ARTICLE; CHROMOSOME 13Q; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN METHYLATION; TUMOR SUPPRESSOR GENE;

ADENOMA; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RETINOBLASTOMA; HUMANS; PITUITARY NEOPLASMS; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA PROTEIN;

EID: 0034161905     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Friend, S. H., Bernards, R., Rogelji, S., Weinberg, R. A., Rapaport, J. M., Alberts, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 643-646, 1986.
2. Fung, Y-K. T., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H., and Benedict, W. F. Structural evidence for the authenticity of the human retinoblastoma gene. Science (Washington DC), 236: 1657-1661, 1987.
3. Lee, W. H., Bookstein, R., Hong, F., Young, L-J., Shew, J-Y., and Lee, E. Y-H. P. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (Washington DC), 235: 1394-1399, 1987.
4. Lee, W. H., Shew, J. Y., Hong, F., Sery, T., Donoso, L. A., Young, L. J., Bookstein, R., and Lee, E. Y. H. P. The retinoblastoma susceptibility gene product is a nuclear phosphoprotein associated with DNA binding activity. Nature (Lond.), 329: 642-645, 1987.
5. Buchkovich, K., Duffy, L. A., and Harlow, E. The retinoblastoma gene is phosphorylated during specific phases of the cell cycle. Cell, 58: 1097-1105, 1989.
6. Ishikawa, J., Xu, H-J., Yandell, D. W., Maeda, S., Kamidono, S., Benedict, W. F., and Takahashi, R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res., 51: 5736-5743, 1991.
7. Hogg, A., Bia, B., Onadim, Z., and Cowell, K. Molecular mechanism of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. Proc. Natl. Acad. Sci. USA, 90: 7351-7355, 1993.
8. Xu, H. J., Cairns, P., Hu, S. X., Knowles, M. A., and Benedict, W. F. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int. J. Cancer, 53: 781-784, 1993.
9. Gouyer, V., Gazzeri, S., Brambilla, E., Bolon, I., Moro, D., Perron, P., Benabid, A. L., and Brambilla, C. Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinoma. Int. J. Cancer, 58: 818-824, 1994.
10. Borg, A., Zhang, Q. X., Alm, P., Olsson, H., and Sellberg, G. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res., 52: 2991-2994, 1992.
11. Cooney, K. A., Wetzel, J. C., Merajver, S. D., Macoska, J. A., Singleton, T. P., and Wojno, K. J. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res., 56: 1142-1145, 1996.
12. Bates, A. S., Farrell, W. E., Bicknell, E. J., Talbot, A. J., Broome, J. C., Perrett, C. W., Thakker, R. V., and Clayton, R. N. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J. Clin. Endocrinol. Metab., 82: 818-824, 1997.
13. Simpson, D. J., Magnay, J., Bicknell, J. E., Barkan, A. L., McNicol, A. M., Clayton, R. N., and Farrell, W. E. Chromosome 13q deletion mapping in pituitary tumours: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas. Cancer Res., 59: 2703-2709, 1999.
14. Cryns, V. L., Alexander, J. M., Klibinski, A., and Arnold, A. The retinoblastoma gene in human pituitary tumors. J. Clin. Endocrinol. Metab., 77; 644-646, 1993.
15. Woloschak, M., Roberts, J. L., and Post, K. D. Loss of heterozygosity at the retinoblastoma gene locus in human pituitary tumors. Cancer (Phila.), 74: 693-696, 1994.
16. Zhu, J., Leon, S. P., Beggs, A. H., Busque, L., Giliiland, D. G., and Black, P. M. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J. Clin. Endocrinol. Metab., 78: 922-927, 1994.
17. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., Benedict, W. F., and Prager, D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumour suppressor other than RB. Cancer Res., 55: 1613-1616, 1995.
18. Sakai, T., Ohtani, N., McGee, T. L., Robbins, P. D., and Dryja, T. P. Oncogenic germ-line mutations in SpI and ATF sites in the human retinoblastoma gene. Nature (Lond.), 353: 83-86, 1991.
19. Bookstein, R., Rio, P., Madreperia, S. A., Hong, F., Allred, C., Grizzle, W. E., and Lee, W. H. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad, Sci. USA, 87: 7762-7766, 1990.
20. Yandell, D. W., Campbell, T. A., Dayton, S. H., Petersen, R., Walton, D., Little, J. B., McConkie-Rosell, A., Buckley, E. G., and Dryja, T. P. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counselling. N. Engl. J. Med., 21: 1689-1695, 1989.
21. Mori, N., Yokota, J., Akiyama, T., Sameshima, Y., Okamoto, A., Mizoguchi, H., Toyoshima, K., Sugimura, T., and Terada, M. Variable mutation of the RB gene in small-cell lung carcinoma. Oncogene, 11: 1713-1717, 1990.
22. Hensel, C. H., Hsieh, C-L., Gazdar, A. F., Johnson, B. E., Sakaguchi, A. Y., Naylor, S. L., Lee, W-H., and Lee, E. Y-H. P. Altered structured and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res., 50: 3067-3072, 1990.
23. Bookstein, R., Shew, J-Y., Chen, P-L., Scully, P., and Lee, W-H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Washington DC), 247: 712-715, 1990.
24. Jones, P. A. DNA methylation errors and cancer. Cancer Res., 56: 2463-2467, 1996.
25. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J-P. Alteration in DNA methylation: a fundamental aspect of neoplasia. In: G. F. Vande Woude and G. Kleine (eds.), Advances in Cancer Research, Vol. 72, pp. 141-196. San Diego: Academic Press, Inc., 1998.
26. Stirzaker, C., Millar, S., Paul, C. L., Warnecke, P. M., Harrison, J., Vincent, P. C., Frommer, M., and Clark, S. J. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res., 57: 2229-2237, 1997.
27. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., and Rapaport, J. M. Allele-specific hypermethylation of the retinoblastoma tumour-suppressor gene. Am. J. Hum. Genet., 48: 880-888, 1991.
28. Greger, V., Debus, N., Lohmann, D., Hopping, W., Passarge, E., and Horsthemke, B. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum. Genet., 94: 491-496, 1994.
29. Ohtani-Fujita, N., Dryja, T. P., Rapaport, J. M., Fujita, T., Matsumura, S., Ozasa, K., Watanabe, Y., Hayashi, K., Maeda, K., Kinoshita, S., Matsumura, T., Ohnishi, Y., Hotla, Y., Takahashi, R., Kato, M. V., Ishizaki, K., Sasaki, M. S., Horsthemke, S. B., Minoda, K., and Sakai, T. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet. Cytogenet., 98: 43-49, 1997.
30. Ohtani-Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D., and Sakai, T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene, 8: 1063-1067, 1993.
31. Boggild, M. D., Jenkinson, S., Pistorello, M., Bascaro, M., Scanarini, M., McTernan, P., Perrett, C. W., Thakker, R. V., and Clayton, R. N. Molecular genetic studies of sporadic pituitary tumours. J. Clin. Endocrinol. Metab., 78: 387-392, 1994.
32. Geradts, J., and Kratzke, R. A. Wild type and mutant retinoblastoma protein in paraffin sections. Mod. Pathol., 9: 339-347, 1996.
33. Grigg, G. W. Sequencing 5-methylcytosine residues by the bisulphite method. DNA Seq., 6: 189-198, 1996.
34. Herman, J. G., Graff, J. R., Myöhanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG island. Proc. Natl. Acad. Sci. USA. 93: 9821-9826, 1996.
35. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. A genomic sequencing protocol that yield a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89: 1827-1831, 1992.
36. Di Fiore, B., Palena, A., Felsani, A., Palitti, F., Carcuso, M., and Lavia, P. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2). Nucleic Acids Res., 27: 2852-2859, 1999.
37. Zingg, J-M., and Jones, P. A. Genetic and epigentic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis (Lond.), 18: 869-882, 1997.
38. Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
39. Farrell, W. E., and Clayton, R. N. Molecular genetics of pituitary tumours. Trends Endocrinol. Metab., 9: 20-26, 1998.
40. Farrell, W. E., Simpson, D. J., Bicknell, E. J., Talbot, A. J., Bates, A. S., and Clayton, R. N. Chromosome 9p deletions in invasive and non-invasive non-functional pituitary adenomas; the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res., 57: 2703-2709, 1997.
41. Gill, M. R., Hamel, P. A., Jiang, Z., Zacksenhaus, E., Gallie, B. L., and Phillips, R. A. Characterization of the human RB1 promoter and elements involved in the transcriplional regulation. Cell Growth Differ., 5: 467-474, 1994.